Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 -0.02 (-0.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Share-based Compensation (2018 - 2026)

Updated

Fulcrum Therapeutics (FULC) reported Share-based Compensation of $3.27 million for Q2 2026, up 13.8% from $2.88 million a year earlier but down 15.3% from the prior quarter.

Analysis

Fulcrum Therapeutics (FULC) Share-based Compensation (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Fulcrum Therapeutics' Share-based Compensation came in at $13.56 million, up 9.9% year-over-year; for FY2025, it came in at $12.47 million, down 14.3% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $14.55 million in FY2024 (-1.7%), $14.8 million in FY2023 (+10.9%), $13.35 million in FY2022 (+20.6%) and $11.07 million in FY2021 (+50.6%).
  • Five-year quarterly Share-based Compensation spans a low of $2.48 million in Q4 2024 and a high of $4.34 million in Q2 2024.
  • Year over year, Share-based Compensation has now increased in each of the last three quarters, with an average decline of 3.9% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 126.2%); the low point was Q2 2025 (a decline of 33.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.86 million (Q1 2026), $3.07 million (Q4 2025) and $3.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Fulcrum Therapeutics 283.78 Mn 283.78 Mn - 3.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.27 Mn
Mar 31, 2026 3.86 Mn
Dec 31, 2025 3.07 Mn
Sep 30, 2025 3.36 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 3.17 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 3.82 Mn
Jun 30, 2024 4.34 Mn
Mar 31, 2024 3.92 Mn
Dec 31, 2023 3.45 Mn
Sep 30, 2023 3.74 Mn
Jun 30, 2023 3.36 Mn
Mar 31, 2023 4.25 Mn
Dec 31, 2022 3.27 Mn
Sep 30, 2022 3.35 Mn
Jun 30, 2022 2.88 Mn
Mar 31, 2022 3.85 Mn
Dec 31, 2021 3.79 Mn
Sep 30, 2021 2.66 Mn
API Access

Fulcrum Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=FULC&period=max&api_key=YOUR_API_KEY